Page last updated: 2024-09-03

me 2303 and Ovarian Neoplasms

me 2303 has been researched along with Ovarian Neoplasms in 1 studies

*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlow, AL; Gaze, MN; Huxham, IM; Lewis, AD; Mairs, RJ; Plumb, J; Workman, P1

Other Studies

1 other study(ies) available for me 2303 and Ovarian Neoplasms

ArticleYear
Differential intracellular processing of the anthracycline drug ME2303 in doxorubicin-sensitive (A2780) and -resistant (A2780AD) human ovarian cancer cells as studied with confocal laser scanning microscopy and image analysis.
    International journal of cancer, 1994, Oct-01, Volume: 59, Issue:1

    Topics: Coloring Agents; Doxorubicin; Drug Resistance; Female; Fluorescence; Golgi Apparatus; Humans; Image Processing, Computer-Assisted; Microscopy, Confocal; Ovarian Neoplasms; Oxidation-Reduction; Tumor Cells, Cultured

1994